Search Results - Daniel T. Baptista‐Hon
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
Leveraging foundation and large language models in medical artificial intelligence by Io Nam Wong, Olivia Monteiro, Daniel T. Baptista-Hon, Kai Wang, Wenyang Lu, Zhuo Sun, Sheng Nie, Yun Yin, Jing Ni
Published in Chinese Medical Journal (2024-11-01)Get full text
Article -
6
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant by Gen Li, Zhongcheng Zhou, Peng Du, Meixiao Zhan, Ning Li, Xinxin Xiong, Shengjun Tang, Miao Man, Daniel T. Baptista-Hon, Ligong Lu
Published in Signal Transduction and Targeted Therapy (2022-07-01)Get full text
Article -
7
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C by Zhongcheng Zhou, Peng Du, Meixing Yu, Daniel T. Baptista-Hon, Man Miao, Andy P. Xiang, Johnson Yiu-Nam Lau, COVID-19 Immunity Investigation Group, Gen Li, Kang Zhang
Published in Signal Transduction and Targeted Therapy (2021-07-01)Get full text
Article -
8
Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions by Laurence Si Chong Lok, Shuvam Sarkar, Calista Chi In Lam, Chak Fun Law, Sin Teng Chau, Chun Yip Thomas Leung, Wai Hin Cheang, Ting Li, Olivia Monteiro, Daniel Tomas Baptista‐Hon
Published in MedComm – Future Medicine (2024-12-01)Get full text
Article -
9
Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant by Zhongcheng Zhou, Peng Du, Ning Li, Xinxin Xiong, Shengjun Tang, Qinjin Dai, Taorui Wang, Meixing Yu, Miao Man, Kelvin Lam, Daniel T. Baptista‐Hon, Wa Hou Tai, Olivia Monteiro, Weng Sam Ng, Un Man Lee, Zhihai Liu, Kang Zhang, Gen Li
Published in MedComm (2022-06-01)Get full text
Article
